---
schema_version: "secwatch.filing_event.v1"
accession: "0001682852-22-000045"
form_type: "8-K"
ticker: "MRNA"
cik: "0001682852"
company_name: "Moderna, Inc."
filed_at: "2022-09-29T23:59:59+00:00"
generated_at: "2026-06-23T06:43:59.663060+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Moderna appoints Andres to new President role, Collins as CTOQO effective Jan 1, 2023

## Summary
- Juan Andres transitions to President, Strategic Partnerships and Enterprise Expansion; retains Executive Committee seat.
- Jerh Collins joins as Chief Technical Operations & Quality Officer, effective Jan 1, 2023; from Novartis with 30 yrs manufacturing experience.
- Executive Committee expanded to prepare for multiple new product launches; Andres led COVID vaccine production.
- Collins will focus on expanding production footprint globally; starts Oct 3, 2022, assumes role Jan 1, 2023.

## SEC filing metadata
- accession: 0001682852-22-000045
- form_type: 8-K
- ticker: MRNA
- cik: 0001682852
- company_name: Moderna, Inc.
- filed_at: 2022-09-29T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/0001682852-22-000045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/mrna-20220929.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001682852-22-000045
- JSON: https://secwatch.observer/filing/0001682852-22-000045.json
- Plain text: https://secwatch.observer/filing/0001682852-22-000045.txt

## Key facts
- Executive change
  Juan Andres changed role as President, Strategic Partnerships and Enterprise Expansion at Moderna, Inc..
  - Action: will transition into
  - Role: President, Strategic Partnerships and Enterprise Expansion
  source text: On September 29, 2022, Moderna, Inc. (the “Company”) announced that Juan Andres, the Company’s Chief Technical Operations and Quality Officer, will transition into a new role as President, Strategic Partnerships and Enterprise Expansion of the Company, effective January 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/0001682852-22-000045-index.htm
- Executive change
  Jerh Collins was appointed as Chief Technical Operations and Quality Officer at Moderna, Inc..
  - Action: will assume
  - Role: Chief Technical Operations and Quality Officer
  source text: The Company further announced that Dr. Jerh Collins, Ph.D., who will join the Company on O ctober 3, 2022, will assume the role of Chief Technical Operations and Quality Officer of the Company, effective January 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1682852/000168285222000045/0001682852-22-000045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.